HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Clinical trial NCT03850795 · TERMINATED

Trial details

NCT number: NCT03850795
Sponsor: Hinova Pharmaceuticals USA, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2021-03-15
Primary completion: 2024-06-28
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.